Rheumatoid Arthritis Posts on Medivizor
Navigation Menu

Rheumatoid Arthritis Posts on Medivizor

Remission and risk of serious infection in patients with rheumatoid arthritis

Posted by on Dec 11, 2017 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated if remission had any impact on the risk of infection in patients with rheumatoid arthritis. They found that the incidence of serious infection was significantly lower in patients in remission from rheumatoid arthritis. Some background Rheumatoid arthritis (RA) is a chronic condition that is caused by the...

Read More

SB2: a safe and effective switch from infliximab for patients with rheumatoid arthritis?

Posted by on Dec 4, 2017 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated the safety and effectiveness of switching to SB2 from infliximab (Remicade) in patients with rheumatoid arthritis. They found that switching to SB2 from infliximab was well tolerated and effective at reducing disease activity. Some background Rheumatoid arthritis (RA) is a chronic disease that causes...

Read More

Are patients with rheumatoid arthritis at a greater risk of hospitalization for chronic obstructive pulmonary disorder (COPD)?

Posted by on Dec 4, 2017 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated whether there is an increased risk of hospitalization for chronic obstructive pulmonary disorder in rheumatoid arthritis patients. They found that patients with rheumatoid arthritis had a greater risk of hospitalization for COPD compared to the general population. Some background Rheumatoid arthritis (RA) is...

Read More

Is tofacitinib useful in treating atherosclerosis in patients with rheumatoid arthritis?

Posted by on Nov 27, 2017 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated if tofacitinib improves atherosclerosis in patients with rheumatoid arthritis. They found that tofacitinib improved disease activity and atherosclerosis in patients with rheumatoid arthritis. Some background Patients with rheumatoid arthritis (RA) have an increased risk of cardiovascular (heart and circulatory...

Read More

Ultrasound of the hand: can this detect rheumatoid arthritis during remission?

Posted by on Nov 9, 2017 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated if ultrasound of the hand can accurately detect inflammation in patients with rheumatoid arthritis in remission. They found that ultrasound detected inflammation in a high number of patients in clinical remission of rheumatoid arthritis. Some background Ultrasound (US) is used to determine if a patient with...

Read More

Rheumatoid arthritis: is there any benefit to intensifying treatment in patients with low disease activity?

Posted by on Nov 9, 2017 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated if intensifying treatment during low disease activity was beneficial in patients with rheumatoid arthritis (RA). They found that patients with low disease activity do not benefit from treatment intensification. Some background Management of rheumatoid arthritis (RA) involves treating patients with...

Read More

Is certolizumab pegol an effective medication for the treatment of rheumatoid arthritis?

Posted by on Oct 30, 2017 in Rheumatoid Arthritis | 0 comments

In a nutshell This study reviewed data on clinical trials investigating the effects of certolizumab pegol (Cimzia) for the treatment of rheumatoid arthritis. They found that certolizumab pegol is an effective medication for the treatment of rheumatoid arthritis. Some background Rheumatoid arthritis (RA) is an autoimmune disease that causes...

Read More

Does baricitinib improve patient reported outcomes in the treatment of rheumatoid arthritis?

Posted by on Oct 30, 2017 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated the patient reported outcomes (PRO) in patients receiving baricitinib (Olumiant) and methotrexate (Trexall). They found that patients receiving baricitinib had greater improvement in PRO compared to methotrexate alone. Some background Rheumatoid arthritis (RA) is an autoimmune disease where the...

Read More

Biological treatments do not increase cancer risk in rheumatoid arthritis

Posted by on Oct 23, 2017 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated if there is an increased risk of cancer in rheumatoid arthritis patients taking immunomodulating drugs. They found that there was no increased cancer risk in patients taking biological DMARDs compared to conventional synthetic DMARDs. Some background Rheumatoid arthritis (RA) is a chronic inflammatory...

Read More

Are disease-modifying anti-rheumatic drugs (DMARDs) a safe, long-term treatment for rheumatoid arthritis?

Posted by on Oct 18, 2017 in Rheumatoid Arthritis | 0 comments

In a nutshell This study analyzed the safety of disease-modifying anti-rheumatic drugs (DMARDs) for the treatment of rheumatoid arthritis (RA). They found that patients taking biological DMARDs had a higher risk of infections compared to synthetic DMARDs. Some background Rheumatoid arthritis (RA) is an auto-immune condition which causes...

Read More

Thromboembolism risk in patients with inflammatory conditions including rheumatoid arthritis

Posted by on Oct 3, 2017 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated if there was a risk of thromboembolism (blood clots) in patients with rheumatoid arthritis, psoriasis or psoriatic arthritis. They found that patients with rheumatoid arthritis had a greater risk of thromboembolism. Some background Rheumatoid arthritis (RA) is a condition that causes pain and inflammation in...

Read More